guanfacine has been researched along with Brain Injuries in 2 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guanfacine was associated with improved WM performance in the MTBI but not the HC group." | 2.76 | Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response. ( Ferrell, RB; Flashman, LA; Grove, MR; McAllister, TW; McDonald, BC; Saykin, AJ; Tosteson, TD; Yanofsky, NN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McAllister, TW | 1 |
| McDonald, BC | 1 |
| Flashman, LA | 1 |
| Ferrell, RB | 1 |
| Tosteson, TD | 1 |
| Yanofsky, NN | 1 |
| Grove, MR | 1 |
| Saykin, AJ | 1 |
| Friedrich, MJ | 1 |
1 trial available for guanfacine and Brain Injuries
| Article | Year |
|---|---|
Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Brain; Brain Injuries; Brain Mapping; Cognition Disorde | 2011 |
1 other study available for guanfacine and Brain Injuries
| Article | Year |
|---|---|
Researchers seek new ways to counter the harmful toll of stress on the brain.
Topics: Antihypertensive Agents; Brain Injuries; Catecholamines; Guanfacine; Humans; Prazosin; Prefrontal Co | 2013 |